by Jordana Choucair | May 17, 2022 | Life Sciences
Twenty-four states filed a legal brief supporting the federal government’s battle against six drugmakers over 340B restrictions. The states said that the drugmakers – AstraZeneca, Eli Lilly, Novartis, Novo Nordisk, Sanofi, and United Therapeutics – unlawfully cut off...
by Jordana Choucair | May 16, 2022 | Life Sciences
Novavax officials said they are confident that the Food and Drug Administration (FDA) will grant their COVID-19 vaccine an emergency use authorization early next month. Novavax received $1.6 billion from the federal government to speed the development of the shots...
by Jordana Choucair | May 13, 2022 | Life Sciences
The White House announced it is licensing COVID-19 technologies to the World Health Organization to enable global manufacturers to make COVID-19 shots and increase testing capability. The 11 technologies, including the stabilized spike protein used in many coronavirus...
by Jordana Choucair | May 11, 2022 | Life Sciences
According to a new report from House Democrats, executives at contract vaccine manufacturer Emergent BioSolutions covered up quality control problems that led to more than 400 million doses of coronavirus vaccines needing to be trashed. BioSolutions had more than $1.3...
by Jordana Choucair | May 6, 2022 | Life Sciences
The Food and Drug Administration (FDA) announced that it is limiting the authorization for the Johnson & Johnson COVID-19 to adults age 18 and older who cannot or will not get the Pfizer or Moderna vaccines. The agency said it was making the change because of the...
by Jordana Choucair | May 5, 2022 | Life Sciences
The House Energy and Commerce Committee released a user fee authorization bill that would allow regulators to revoke approval for drugs cleared through the accelerated approval program if drugmakers delay their required follow-up trials. A stronger measure from an...
Recent Comments